Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Runyon

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Invasive Cardiology|March 24, 2000
Facilitated percutaneous coronary intervention: validating the open artery hypothesisJ P Runyon
The Journal of Invasive Cardiology|January 13, 2001
Rapid dissolution of intracoronary thrombus with eptifibatide therapy in a patient with post-infarction anginaJ P Runyon, D D Snavely
The American Journal of Cardiology|May 4, 2000
IIb's are not IIb'sD J Kereiakes, J P Runyon, T M Broderick, et al.
The Journal of Invasive Cardiology|June 1, 2001
Ticlopidine monotherapy following coronary stent deployment: "penny wise and pound foolish"D J Kereiakes, J J Young, J P Runyon, et al.
The American Journal of Cardiology|November 15, 1996
Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusionD J Kereiakes, J H Essell, C W Abbottsmith, et al.
Journal of Electrocardiology|January 1, 1993
Serial 12-lead electrocardiographic monitoring in patients presenting to the emergency department with chest painW B Gibler, M R Sayre, R C Levy, et al.
Circulation|September 1, 1996
Differential dose-response to oral xemilofiban after antecedent intravenous abciximab. Administration for complex coronary interventionD J Kereiakes, J P Runyon, N S Kleiman, et al.
Annals of Emergency Medicine|January 1, 1995
A rapid diagnostic and treatment center for patients with chest pain in the emergency departmentW B Gibler, J P Runyon, R C Levy, et al.
The American Journal of Cardiology|September 1, 1999
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary interventionD J Kereiakes, T M Broderick, E M Roth, et al.
Circulation|August 19, 1997
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deploymentD J Kereiakes, N Kleiman, J J Ferguson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Invasive Cardiology|March 24, 2000
Facilitated percutaneous coronary intervention: validating the open artery hypothesisJ P Runyon
The Journal of Invasive Cardiology|January 13, 2001
Rapid dissolution of intracoronary thrombus with eptifibatide therapy in a patient with post-infarction anginaJ P Runyon, D D Snavely
The American Journal of Cardiology|May 4, 2000
IIb's are not IIb'sD J Kereiakes, J P Runyon, T M Broderick, et al.
The Journal of Invasive Cardiology|June 1, 2001
Ticlopidine monotherapy following coronary stent deployment: "penny wise and pound foolish"D J Kereiakes, J J Young, J P Runyon, et al.
The American Journal of Cardiology|November 15, 1996
Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusionD J Kereiakes, J H Essell, C W Abbottsmith, et al.
Journal of Electrocardiology|January 1, 1993
Serial 12-lead electrocardiographic monitoring in patients presenting to the emergency department with chest painW B Gibler, M R Sayre, R C Levy, et al.
Circulation|September 1, 1996
Differential dose-response to oral xemilofiban after antecedent intravenous abciximab. Administration for complex coronary interventionD J Kereiakes, J P Runyon, N S Kleiman, et al.
Annals of Emergency Medicine|January 1, 1995
A rapid diagnostic and treatment center for patients with chest pain in the emergency departmentW B Gibler, J P Runyon, R C Levy, et al.
The American Journal of Cardiology|September 1, 1999
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary interventionD J Kereiakes, T M Broderick, E M Roth, et al.
Circulation|August 19, 1997
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deploymentD J Kereiakes, N Kleiman, J J Ferguson, et al.
Pageof 2